Hot Papers

P. Sassone-Corsi, J.C. Sisson, I.M. Verma, "Transcriptional autoregulation of the proto-oncogene fos," Nature, 334, 314-9, 28 July 1988. Inder M. Verma (The Salk Institute, San Diego): "The paper showed for the first time that the transcription of nuclear oncogenes is autoregulated. It is generally believed that many nuclear oncoproteins can cause cancer if they are transcribed in an unregulated fashion. Autoregulation is one way to regulate their transcription. We showed that fos protein can

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

P. Sassone-Corsi, J.C. Sisson, I.M. Verma, "Transcriptional autoregulation of the proto-oncogene fos," Nature, 334, 314-9, 28 July 1988.

Inder M. Verma (The Salk Institute, San Diego): "The paper showed for the first time that the transcription of nuclear oncogenes is autoregulated. It is generally believed that many nuclear oncoproteins can cause cancer if they are transcribed in an unregulated fashion. Autoregulation is one way to regulate their transcription. We showed that fos protein can shut off the transcription of its own promoter; therefore, the amounts of the fos protein are modulated very tightly. This manuscript set the stage for identifying other oncoproteins that are regulated in a similar fashion. This intricate mechanism of regulation shows how cancer genes can become transforming if they are synthesized in an inappropriate place and perhaps at an inappropriate level."

G. Draetta, D. Beach, "Activation of cdc2 protein kinase during mitosis in human cells: cell ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies